주요서비스 바로가기
본문 바로가기
매체정보 바로가기
로그인 바로가기
기사검색 바로가기
전체서비스 바로가기
상단영역
UPDATE : 2024-04-26 16:52 (Fri)
Home
Log in
Join
전체메뉴
기사검색
검색
본문영역
All articles
목록
(
총 :
6,352 )
기사목록 보기 형태
제목형
요약형
포토형
‘Thyroid-stimulating hormone suppression therapy increases cardiovascular disease risk’
Lee Han-soo
2021.09.13 11:44
Samsung Bioepis confirms safety, efficacy of trastuzumab biosimilar for breast cancer
Shim Hyun-tai
2021.09.13 11:44
Opinions divided over bridging study for abortion pill Mifegymiso
Kim Chan-hyuk
2021.09.13 11:43
Hanmi keeps challenging Pfizer’s Champix in smoking cessation drug market
Shim Hyun-tai
2021.09.12 10:29
Original erectile dysfunction treatments overcome by generic copies
Lee Han-soo
2021.09.11 10:13
Merck’s multiple sclerosis therapy safe, effective after Covid-19 vaccination
Shim Hyun-tai
2021.09.10 18:12
Korea considers expanding vaccine incentives, simplifying quarantine rules
Lee Han-soo
2021.09.10 18:11
Samsung Bioepis confident of its biosimilar’s effects on macular degeneration
Shim Hyun-tai
2021.09.10 16:32
‘Temporary cost support for Spravato should be considered for urgent cases’
Kim Yun-mi
2021.09.10 15:16
Korea’s 1st ‘private-led cluster for new drug development’ to open
Kim Chan-hyuk
2021.09.10 14:32
Helixmith starts P2a study of VM202 treating amyotrophic lateral sclerosis.
Lee Han-soo
2021.09.10 12:54
'Medytox may market its BTX product through Evolus'
Lee Han-soo
2021.09.10 12:50
처음
이전
이전
이전
521
522
523
524
525
526
527
528
529
530
끝
위로
전체메뉴
All
Hospital
Pharma
Bio
All
Korea‘s Bio Industry
Device/ICT
Policy
People
Life science
Special
All
Innovation for Survival
Korea’s medical culture series
Korea’s New Candidate Drug Watch List
Special Series in Celebration of KBR's 1st Anniversary
Interview with foreign envoys
Special Series in Celebration of KBR’s 2nd Anniversary
Interview with global pharma
Special Series in Celebration of KBR’s 3rd Anniversary
ASCO 2020 Highlights
Special Series in Celebration of KBR’s 4th Anniversary
KBR Covering RSNA 2021
Special Series in Celebration of KBR’s 5th Anniversary
Special Report on EULAR 2022
[Top K-Pharma Analysis]
BIO 2023
Opinion
All
Reporter’s Notebook
Journalist’s Column
Congratulatory Remarks
Sponsored
전체메뉴닫기